ListarEnfermidades endocrinas, nutricionais e metabólicas por tema "Dopamine agonists"

Mostrando ítems 1-2 de 2

    • Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma 

      Iglesias, Pedro; Biagetti, Betina; Araújo-Castro, Marta; Alcázar, Victoria; Guerrero-Pérez, Fernando; Rivero, Noelia; Casteràs, Anna; García Izquierdo, Belén; García Gómez, Carlos; Viedma Torres, Víctor; Pascual-Corrales, Eider; Pavón, Isabel; Villabona, Carles; Cordido, Fernando; Díez, Juan J. (Springer, 2022-11-10)
      [Abstract] Background: In recent years, dopamine agonists (DAs) have become an attractive therapeutic option to prevent both tumor growth and post-surgical tumor remnant growth in clinically non-functioning pituitary adenoma ...

    • Practical guidelines for diagnosis and treatment of acromegaly 

      Cordido, Fernando; García-Arnés, Juan Antonio; Marazuela, Mónica; Torres Vela, Elena (Elsevier, 2013-10)
      [Abstract] Acromegaly and gigantism are due to excess GH secretion, usually by a pituitary adenoma. It is an uncommon disease. Diagnosis is made by showing elevated GH and IGF-I levels in patients with a clinical picture ...